“…Further evaluation excluded 80 full texts. Ultimately, 22 articles were included(Garvelink et al., 2017 ; Goel et al., 2001 ; Green et al., 2004 ; Hersch et al., 2015 ; Klaassen et al, 2018 ; Lam et al., 2014 ; Lee et al., 2010 ; Luan et al., 2016 ; Manne et al., 2015 ; Mathieu et al., 2010 ; Metcalfe et al., 2017 ; Molenaar et al., 2001 ; Osaka & Nakayama, 2017 ; Parkinson et al., 2018 ; Perez‐Lacasta et al., 2019 ; Politi et al., 2019 ; Stankowski‐Drengler et al., 2019 ; Street et al., 1995 ; Tucholka et al., 2018 ; Vodermaier et al., 2009 , 2011 ; Whelan et al., 2004 ) (Figure 1 ) which comprised 17 articles that evaluated decision aids for breast cancer treatment, and five on breast cancer screening. Trials were conducted in the United States (8), Canada (3), Australia (3), the Netherlands (3), Germany (2), China (1), Japan (1) and Spain (1) (Table 1 ).…”